
The move toward using the Digital Application Dataset Integration (DADI) project for the initial implementation of IDMP-based regulatory data submissions offers both opportunities and challenges for pharmaceutical organizations.
Renato Rjavec is director of product management at Amplexor Life Sciences.

Published: May 2nd 2022 | Updated: